The landscape of modern medicine is undergoing a seismic shift as we move away from traditional small-molecule drugs toward personalized biological interventions. This transition is heavily dependent on the infrastructure provided by specialized manufacturing partners who can handle the complexities of viral vector production and cryogenic logistics. As pharmaceutical giants pivot their...
Bangla